Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 4,451–4,500 of 4,689 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06452160	A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors	recruiting	Phase 1	103	BridGene Biosciences Inc.INDUSTRY	1	Aug 9, 2024	clinicaltrials
NCT06544720	SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas	recruiting	Phase 1	18	The Affiliated Hospital of Qingdao UniversityOTHER	1	Aug 9, 2024	clinicaltrials